Mariner
TAK icon

Mariner’s Takeda Pharmaceutical TAK Stock Holding History

Mariner’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.94M Buy
308,157
+73,169
+31% +$1.21M 0.01% 1042
2026
Q1 		$4.35M Buy
234,988
+47,348
+25% +$831K 0.01% 1111
2025
Q4 		$2.93M Sell
187,640
-61,331
-25% -$877K ﹤0.01% 1284
2025
Q3 		$3.64M Sell
248,971
-20,803
-8% -$309K ﹤0.01% 1077
2025
Q2 		$4.17M Buy
269,774
+105,141
+64% +$1.55M 0.01% 946
2025
Q1 		$2.45M Buy
164,633
+22,129
+16% +$310K ﹤0.01% 1128
2024
Q4 		$1.89M Buy
142,504
+17,525
+14% +$241K ﹤0.01% 1251
2024
Q3 		$1.78M Buy
124,979
+14,581
+13% +$207K ﹤0.01% 1250
2024
Q2 		$1.43M Buy
110,398
+12,584
+13% +$167K ﹤0.01% 1291
2024
Q1 		$1.36M Buy
97,814
+23,472
+32% +$341K ﹤0.01% 1314
2023
Q4 		$1.06M Sell
74,342
-19,175
-21% -$272K ﹤0.01% 1384
2023
Q3 		$1.45M Sell
93,517
-1,945
-2% -$30.1K ﹤0.01% 1135
2023
Q2 		$1.5M Buy
95,462
+4,044
+4% +$66.3K ﹤0.01% 1092
2023
Q1 		$1.51M Buy
91,418
+16,863
+23% +$269K ﹤0.01% 1081
2022
Q4 		$1.16M Sell
74,555
-10,133
-12% -$142K ﹤0.01% 1162
2022
Q3 		$1.1M Buy
84,688
+62,278
+278% +$866K ﹤0.01% 1010
2022
Q2 		$315K Sell
22,410
-183
-0.8% -$2.61K ﹤0.01% 1272
2022
Q1 		$324K Buy
+22,593
New +$332K ﹤0.01% 1268

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Mariner's TAK Position: Q2 2026 in Review

Mariner increased its Takeda Pharmaceutical (TAK) stake by 31% in Q2 2026, buying an estimated $1.21M and bringing the position to 308,157 shares worth $4.94M. The position accounts for 0.01% of the portfolio, ranked #1042.

Mariner first reported a position in TAK in Q1 2022 and has held it in 18 quarters since. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Mariner held 308,157 shares of Takeda Pharmaceutical worth $4.94M as of Q2 2026.
  • Mariner bought 73,169 Takeda Pharmaceutical shares in Q2 2026, an estimated $1.21M.
  • Takeda Pharmaceutical made up 0.01% of Mariner's portfolio in Q2 2026, its #1042 holding.
  • Mariner first reported a position in Takeda Pharmaceutical in Q1 2022 and has held it in 18 quarters since.
  • 378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.